CBS Logo
AdobeStock_712273576

News, events, and resources

Jan 12, 2026

New Head of West Coast business development at CBS, Allan Cortes! New Head of West Coast business development at CBS, Allan Cortes! Allan Cortes joins CBS as Head of West Coast business development, bringing unparalleled experience in biotech and CRO business development.

Dec 22, 2025

Meet Us at WCBP 2026: All Symposium Details Included Meet Us at WCBP 2026: All Symposium Details Included Crystal Bio Solution is attending as exhibitor at WCBP 2026. What is WCBP, who should attend, and why it matters for CMC and biologics.

Dec 15, 2025

Sterility Assays in Drug and Device Manufacturing Sterility Assays in Drug and Device Manufacturing Sterility and endotoxin testing define release safety in biologics, ensuring microbial control, regulatory compliance, and patient ...

Dec 15, 2025

Critical Quality Attribute D0 Impact in ADC Modality Critical Quality Attribute D0 Impact in ADC Modality Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.

Dec 15, 2025

Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ...

Nov 21, 2025

Strategies for Antibody-Drug Conjugates Bioanalysis Strategies for Antibody-Drug Conjugates Bioanalysis Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...

Oct 9, 2025

Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD Adjusting Minimal Required Dilution (MRD) from 1:4 to 1:2 in a competitive ligand binding assay improved NAb assay sensitivity 4-fold and ...

Sep 18, 2025

Representative Pooled Matrix Selection is Critical in ADA Assays Representative Pooled Matrix Selection is Critical in ADA Assays Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays

Sep 18, 2025

A Generic LC-MS/MS Solution for ADC PK Bioanalysis A Generic LC-MS/MS Solution for ADC PK Bioanalysis Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...

Sep 18, 2025

An immunogenicity analysis strategy to reduce the interference of soluble target proteins An immunogenicity analysis strategy to reduce the interference of soluble target proteins Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
New Head of West Coast business development at CBS, Allan Cortes! New Head of West Coast business development at CBS, Allan Cortes! Allan Cortes joins CBS as Head of West Coast business development, bringing unparalleled experience in biotech and CRO business development.
Meet Us at WCBP 2026: All Symposium Details Included Meet Us at WCBP 2026: All Symposium Details Included Crystal Bio Solution is attending as exhibitor at WCBP 2026. What is WCBP, who should attend, and why it matters for CMC and biologics.
Sterility Assays in Drug and Device Manufacturing Sterility Assays in Drug and Device Manufacturing Sterility and endotoxin testing define release safety in biologics, ensuring microbial control, regulatory compliance, and patient ...
Critical Quality Attribute D0 Impact in ADC Modality Critical Quality Attribute D0 Impact in ADC Modality Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.
Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ...
Strategies for Antibody-Drug Conjugates Bioanalysis Strategies for Antibody-Drug Conjugates Bioanalysis Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD Adjusting Minimal Required Dilution (MRD) from 1:4 to 1:2 in a competitive ligand binding assay improved NAb assay sensitivity 4-fold and ...
Representative Pooled Matrix Selection is Critical in ADA Assays Representative Pooled Matrix Selection is Critical in ADA Assays Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
A Generic LC-MS/MS Solution for ADC PK Bioanalysis A Generic LC-MS/MS Solution for ADC PK Bioanalysis Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
An immunogenicity analysis strategy to reduce the interference of soluble target proteins An immunogenicity analysis strategy to reduce the interference of soluble target proteins Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...

Subscribe to our newsletter!